|
Towards a general function describing t cell proliferation
|
journal
|
August 1995 |
|
A Nonhuman Primate Model for the Selective Elimination of CD8+ Lymphocytes Using a Mouse-Human Chimeric Monoclonal Antibody
|
journal
|
June 1999 |
|
The Landscape of Persistent Viral Genomes in ART-Treated SIV, SHIV, and HIV-2 Infections
|
journal
|
July 2019 |
|
Optimization and qualification of an 8-color intracellular cytokine staining assay for quantifying T cell responses in rhesus macaques for pre-clinical vaccine studies
|
journal
|
December 2012 |
|
Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1
|
journal
|
July 2014 |
|
Standardized assessment of NAb responses elicited in rhesus monkeys immunized with single- or multi-clade HIV-1 envelope immunogens
|
journal
|
October 2007 |
|
Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection
|
journal
|
May 1997 |
|
Re-emergence of HIV after stopping therapy
|
journal
|
October 1999 |
|
Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
|
journal
|
May 1999 |
|
Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys
|
journal
|
July 2014 |
|
HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption
|
journal
|
June 2016 |
|
Early antibody therapy can induce long-lasting immunity to SHIV
|
journal
|
March 2017 |
|
Ex vivo T cell–based HIV suppression assay to evaluate HIV-specific CD8+ T-cell responses
|
journal
|
May 2010 |
|
Prevention of SIVmac251 reservoir seeding in rhesus monkeys by early antiretroviral therapy
|
journal
|
December 2018 |
|
Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity
|
journal
|
October 2022 |
|
A quantitative approach for measuring the reservoir of latent HIV-1 proviruses
|
journal
|
January 2019 |
|
Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8+ cells
|
journal
|
January 2020 |
|
Prolonged viral suppression with anti-HIV-1 antibody therapy
|
journal
|
April 2022 |
|
Combination anti-HIV antibodies provide sustained virological suppression
|
journal
|
June 2022 |
|
Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic
|
journal
|
April 2019 |
|
Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunity
|
journal
|
February 2020 |
|
Distinct mechanisms of long-term virologic control in two HIV-infected individuals after treatment interruption of anti-retroviral therapy
|
journal
|
October 2021 |
|
Safety and virologic impact of the IL-15 superagonist N-803 in people living with HIV: a phase 1 trial
|
journal
|
January 2022 |
|
Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial
|
journal
|
October 2022 |
|
IL-15 Superagonist NAI in BCG-Unresponsive Non–Muscle-Invasive Bladder Cancer
|
journal
|
January 2023 |
|
Quantifying Residual HIV-1 Replication in Patients Receiving Combination Antiretroviral Therapy
|
journal
|
May 1999 |
|
High frequencies of resting CD4 + T cells containing integrated viral DNA are found in rhesus macaques during acute lentivirus infections
|
journal
|
May 2009 |
|
Post-treatment control of HIV infection
|
journal
|
April 2015 |
|
Regulation of T cell expansion by antigen presentation dynamics
|
journal
|
March 2019 |
|
Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
|
journal
|
November 1997 |
|
Immunotherapy during the acute SHIV infection of macaques confers long-term suppression of viremia
|
journal
|
September 2020 |
|
Eradication Therapies for HIV Infection: Time to Begin Again
|
journal
|
April 2011 |
|
HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time
|
journal
|
March 1996 |
|
Control of SIV Rebound Through Structured Treatment Interruptions During Early Infection
|
journal
|
November 2000 |
|
HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1
|
journal
|
May 2016 |
|
Mamu-B*08-Positive Macaques Control Simian Immunodeficiency Virus Replication
|
journal
|
May 2007 |
|
A Novel Assay for Antibody-Dependent Cell-Mediated Cytotoxicity against HIV-1- or SIV-Infected Cells Reveals Incomplete Overlap with Antibodies Measured by Neutralization and Binding Assays
|
journal
|
November 2012 |
|
Generation of the Pathogenic R5-Tropic Simian/Human Immunodeficiency Virus SHIV AD8 by Serial Passaging in Rhesus Macaques
|
journal
|
May 2010 |
|
Expression of the Major Histocompatibility Complex Class I Molecule Mamu-A*01 Is Associated with Control of Simian Immunodeficiency Virus SIVmac239 Replication
|
journal
|
February 2003 |
|
The High-Frequency Major Histocompatibility Complex Class I Allele Mamu-B*17 Is Associated with Control of Simian Immunodeficiency Virus SIVmac239 Replication
|
journal
|
May 2006 |
|
First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation
|
journal
|
June 2018 |
|
Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study
|
journal
|
March 2013 |
|
A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies
|
journal
|
September 2013 |
|
Innate, non-cytolytic CD8+ T cell-mediated suppression of HIV replication by MHC-independent inhibition of virus transcription
|
journal
|
September 2020 |
|
β-catenin regulates HIV latency and modulates HIV reactivation
|
journal
|
March 2022 |
|
Development and Homeostasis of T Cell Memory in Rhesus Macaque
|
journal
|
January 2002 |
|
Canonical Wnts Mediate CD8 + T Cell Noncytolytic Anti–HIV-1 Activity and Correlate with HIV-1 Clinical Status
|
journal
|
September 2020 |